FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gordan Srkalovic

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Drug Resistance, Neoplasm

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Gordan Srkalovic; Mohamad Hussein
Immunomodulatory compounds (IMiDs) in the treatment of multiple myeloma.
Claire E Saadeh; Gordan Srkalovic
Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
Rachid Baz; Esteban Walker; Mary Ann Karam; Toni K Choueiri; Rony Abou Jawde; K Bruening; Janice Reed; Beth Faiman; Y Ellis; C Brand; Gordan Srkalovic; Steven Andresen; R Knight; Jerome B Zeldis; Mohamad A Hussein
Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gordan Srkalovic (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Gordan Srkalovic; Mohamad Hussein
Immunomodulatory compounds (IMiDs) in the treatment of multiple myeloma.
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2009;9 Suppl 1():3-10.
2008: Claire E Saadeh; Gordan Srkalovic
Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia.
Pharmacotherapy 2008;28(2):281-4.
2006: Rachid Baz; Esteban Walker; Mary Ann Karam; Toni K Choueiri; Rony Abou Jawde; K Bruening; Janice Reed; Beth Faiman; Y Ellis; C Brand; Gordan Srkalovic; Steven Andresen; R Knight; Jerome B Zeldis; Mohamad A Hussein
Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1766-71.
2006: Mohamad A Hussein; Rachid Baz; Gordan Srkalovic; Neeraj Agrawal; Revathi Suppiah; Eric D Hsi; Steven Andresen; Mary Ann Karam; Janice Reed; Beth Faiman; Megan Kelly; Esteban Walker
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(7):889-95.
2006: Sundar Jagannath; Paul G Richardson; Bart Barlogie; James R Berenson; shashank singhal; David Irwin; Gordan Srkalovic; David P Schenkein; Dixie Esseltine; Kenneth C Anderson
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone.
Haematologica 2006;91(7):929-34.
2006: Paul G Richardson; Hannah R Briemberg; Sundar Jagannath; Patrick Y Wen; Bart Barlogie; James Berenson; shashank singhal; David S Siegel; David Irwin; Michael Schuster; Gordan Srkalovic; Raymond Alexanian; S Vincent Rajkumar; Steven A Limentani; Melissa Alsina; Robert Z Orlowski; Kevin Najarian; Dixie Esseltine; Kenneth C Anderson; Anthony A Amato
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3113-20.
2006: Paul G Richardson; Bart Barlogie; James Berenson; shashank singhal; Sundar Jagannath; David Irwin; S Vincent Rajkumar; Gordan Srkalovic; Melissa Alsina; Kenneth C Anderson
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.
Cancer 2006;106(6):1316-9.
2005: Rachid Baz; Liang Li; Kandice Kottke-Marchant; Gordan Srkalovic; Bridget McGowan; Erin Yiannaki; Mary Ann Karam; Beth Faiman; Rony Abou Jawde; Steven Andresen; Jerome B Zeldis; Mohamad A Hussein
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2005;80(12):1568-74.
2005: Claire E Saadeh; Gordan Srkalovic
Acute hypersensitivity reaction to ferric gluconate in a premedicated patient.
The Annals of pharmacotherapy 2005;39(12):2124-7.
2005: James R Berenson; Sundar Jagannath; Bart Barlogie; David T Siegel; Raymond Alexanian; Paul G Richardson; David Irwin; Melissa Alsina; S Vincent Rajkumar; Gordan Srkalovic; shashank singhal; Steven A Limentani; Ruben Niesvizky; Dixie Esseltine; Elizabeth Trehu; David P Schenkein; Kenneth C Anderson
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.
Cancer 2005;104(10):2141-8.
2005: Gordan Srkalovic; Marte G Cameron; Steven R Deitcher; Kandice Kattke-Marchant; Mohamad A Hussein
Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis.
International seminars in surgical oncology : ISSO 2005;2():17.
2005: Sundar Jagannath; Bart Barlogie; James R Berenson; shashank singhal; Raymond Alexanian; Gordan Srkalovic; Robert Z Orlowski; Paul G Richardson; Jessica Anderson; Darrell Nix; Dixie Esseltine; Kenneth C Anderson
Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.
Cancer 2005;103(6):1195-200.
2004: Gordan Srkalovic; Marte G Cameron; Lisa Rybicki; Steven R Deitcher; Kandice Kattke-Marchant; Mohamad A Hussein
Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease.
Cancer 2004;101(3):558-66.
2004: Todd W Kelley; Serhan Alkan; Gordan Srkalovic; Eric D Hsi
Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis.
Leukemia research 2004;28(8):845-50.
2003: Steven R Deitcher; Toni K Choueiri; Gordan Srkalovic; Mohamad A Hussein
Acquired activated protein C resistance in myeloma patients with venous thromboembolic events.
British journal of haematology 2003;123(5):959.
2003: Quan Chen; Subrata Ray; Mohamad A Hussein; Gordan Srkalovic; alex almasan
Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma.
Leukemia & lymphoma 2003;44(7):1209-14.
2003: Paul G Richardson; Bart Barlogie; James Berenson; shashank singhal; Sundar Jagannath; David Irwin; S Vincent Rajkumar; Gordan Srkalovic; Melissa Alsina; Raymond Alexanian; David Siegel; Robert Z Orlowski; David Kuter; Steven A Limentani; Stephanie Lee; Teru Hideshima; Dixie Esseltine; Michael Kauffman; Julian Adams; David P Schenkein; Kenneth C Anderson
A phase 2 study of bortezomib in relapsed, refractory myeloma.
The New England journal of medicine 2003;348(26):2609-17.
2003: Frederic J Reu; Gordan Srkalovic
Undifferentiated thyroglobulin-positive thyroid cancer 45 years after treatment for papillary primary.
Clinical advances in hematology & oncology : H&O 2003;1(4):242; discussion 243.
2003: Tarek Mekhail; Thomas E Hutson; Paul Elson; G Thomas Budd; Gordan Srkalovic; Thomas Olencki; David M Peereboom; Robert Pelley; Ronald M Bukowski
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies.
Cancer 2003;97(1):170-8.
2002: Mohamad A Hussein; Laura Wood; Eric D Hsi; Gordan Srkalovic; Mary Ann Karam; Paul Elson; Ronald M Bukowski
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients.
Cancer 2002;95(10):2160-8.
2002: Gordan Srkalovic; Paul Elson; Beth Trebisky; Mary Ann Karam; Mohamad A Hussein
Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma.
Medical oncology (Northwood, London, England) 2002;19(4):219-26.